Uploaded February 2020 | Updated September 2026, 2 weeks ago
Q&A with artists Nguyen Tan Hoang and Iman Shervington. Moderated by Pato Hebert, an educator, artist, and HIV worker.
MOCA is proud to partner with Visual AIDS for the 30th annual Day With(out) Art by presenting STILL BEGINNING, a program of seven newly commissioned videos by artists Shanti Avirgan, Nguyen Tan Hoang, Carl George, Viva Ruiz, Iman Shervington, Jack Waters/ Victor F.M. Torres, and Derrick Woods-Morrow that respond to the ongoing HIV/AIDS epidemic. Ranging in subject from anti-stigma work in New Orleans to public sex culture in Chicago, these short videos highlight pioneering AIDS activism and stage intergenerational conversations. The program reflects the continued urgency of the HIV/AIDS crisis, emphasizing the persistence of the epidemic and resisting narratives of resolution or conclusion. Over 100 institutions worldwide will screen STILL BEGINNING in recognition of the important work of artists, activists, and cultural workers responding to HIV/AIDS over the past three decades.
Q&A with artists Nguyen Tan Hoang and Iman Shervington. Moderated by Pato Hebert, an educator, artist, and HIV worker.
MOCA is proud to partner with Visual AIDS for the 30th annual Day With(out) Art by presenting STILL BEGINNING, a program of seven newly commissioned videos by artists Shanti Avirgan, Nguyen Tan Hoang, Carl George, Viva Ruiz, Iman Shervington, Jack Waters/ Victor F.M. Torres, and Derrick Woods-Morrow that respond to the ongoing HIV/AIDS epidemic. Ranging in subject from anti-stigma work in New Orleans to public sex culture in Chicago, these short videos highlight pioneering AIDS activism and stage intergenerational conversations. The program reflects the continued urgency of the HIV/AIDS crisis, emphasizing the persistence of the epidemic and resisting narratives of resolution or conclusion. Over 100 institutions worldwide will screen STILL BEGINNING in recognition of the important work of artists, activists, and cultural workers responding to HIV/AIDS over the past three decades.
